EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence in histopathology of inflammatory bowel disease: Toward objective and reproducible assessment of disease activity

Marcelo Fabián Amante

Artificial Intelligence in Gastroenterology · 18.03.2026 · 7 (2)

DOI: 10.35712/aig.v7.i2.118230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Intelligence in Gastroenterology, online erschienen am 18.03.2026. Verfasst von Marcelo Fabián Amante. Die Arbeit nennt 34 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The integration of artificial intelligence (AI) into the histopathological assessment of inflammatory bowel disease (IBD) represents a fundamental paradigm shift toward a new era of computational pathology, promising unprecedented levels of objectivity, reproducibility, and clinical insight. Traditional semiquantitative histological scoring systems while clinically entrenched are intrinsically limited by significant inter-observer variability and subjective interpretation, complicating critical decisions in diagnosis, therapeutic monitoring, and the evaluation of histological remission, an increasingly paramount treatment goal. The advent of whole-slide imaging and sophisticated AI algorithms, particularly deep convolutional neural networks and vision transformers, offers a transformative solution. These technologies enable the automated, pixel-level analysis of mucosal architecture and inflammatory infiltrates, translating visual patterns into quantitative, continuous data. This comprehensive minireview systematically synthesizes the current state of AI applications in IBD histopathology, spanning automated crypt analysis, inflammatory cell quantification, and the prediction of established histological scores and clinical outcomes. It critically examines the potential of AI to operationalize and standardize the endpoint of histological remission, thereby strengthening clinical trials and precision medicine. Furthermore, the manuscript delves into the profound epistemological and practical challenges posed by this technological integration, including algorithmic bias, the “black box” dilemma, and the evolving role of the pathologist as an overseer of AI systems. Finally, it outlines a strategic roadmap for future translation, emphasizing the need for robust multicenter validation, standardized regulatory frameworks, seamless clinical workflow integration, and the cultivation of interdisciplinary expertise to fully realize the potential of AI in optimizing personalized, predictive care for patients with IBD.

Zitieren

APA

Amante, M. F. (2026). Artificial intelligence in histopathology of inflammatory bowel disease: Toward objective and reproducible assessment of disease activity. Artificial Intelligence in Gastroenterology, 7(2). https://doi.org/10.35712/aig.v7.i2.118230

Vancouver

Amante MF. Artificial intelligence in histopathology of inflammatory bowel disease: Toward objective and reproducible assessment of disease activity. Artificial Intelligence in Gastroenterology. 2026;7(2). doi:10.35712/aig.v7.i2.118230

BibTeX
@article{Amante2026,
  author = {Amante, Marcelo Fabián},
  title = {Artificial intelligence in histopathology of inflammatory bowel disease: Toward objective and reproducible assessment of disease activity},
  journal = {Artificial Intelligence in Gastroenterology},
  year = {2026},
  volume = {7},
  number = {2},
  doi = {10.35712/aig.v7.i2.118230}
}
Kostenlos starten →